Christine Rowland has been appointed to the newly created position of value and access manager at the Association of the British Pharmaceutical Industry (ABPI).
Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI’s strategic objectives around health technology assessment and market access.
Rowland joins the ABPI from Pfizer where she spent 12 years in a range of roles, including sales, marketing, and market access, covering areas such as oncology and rare diseases. In addition to 17 years in the pharmaceutical industry, Rowland spent a decade with the NHS as a nurse and midwife.
“I am delighted to join the ABPI at this time of great change in the landscape of the UK health system and the NHS,” Rowland said.
The new role will see her join the ABPI’s 23-strong commercial department. ABPI director of value and access Paul Catchpole said Rowland was a very welcome addition to the team at a time when the APPI is leading an increasing number of commercial initiatives.
“These include the implementation of the new PPRS scheme, working with NICE on value based assessment and helping our members with the changing NHS landscape whilst continuing to push for greater use of newer medicines,” added Catchpole.